Table 3.

Test of Known-Groups Validity, as Assessed by FLU-PRO Plus, Comparing FLU-PRO Plus Domain and Total Scores With 3 Categories of Severity on the Patient Global Assessment of Influenza-like Illness Scale, Using Analysis of Variance and Pairwise t Tests

Scale Patient Global Assessment of ILI SeverityF Value
No/Mild Moderate Severe/Very Severe
(n=148)(n=63)(n=15)
Nose1.0 (0.8)a,b1.5 (1.0)a1.8 (1.2)b10.5
Throat0.4 (0.7)a,b1.2 (1.0)a1.4 (0.9)b24.7
Eyes0.3 (0.6)a,b0.9 (1.0)a,c1.6 (1.1)b,c26.4
Systemic0.8 (0.7)a,b1.8 (0.8)a,c2.5 (0.8)b,c62.9
Respiratory0.6 (0.5)a,b1.3 (0.6)a,c1.7 (0.6)b,c47.7
GI0.4 (0.4)a,b0.8 (0.6)a,c1.3 (0.9)b,c32.7
Senses1.2 (1.5)a,b1.9 (1.6)a2.2 (1.6)b5.6
Total (not including senses)0.6 (0.5)a,b1.4 (0.6)a,c1.9 (0.6)b,c74.4
Total0.6 (0.5)a,b1.4 (0.6)a,c1.9 (0.5)b,c64.1
Scale Patient Global Assessment of ILI SeverityF Value
No/Mild Moderate Severe/Very Severe
(n=148)(n=63)(n=15)
Nose1.0 (0.8)a,b1.5 (1.0)a1.8 (1.2)b10.5
Throat0.4 (0.7)a,b1.2 (1.0)a1.4 (0.9)b24.7
Eyes0.3 (0.6)a,b0.9 (1.0)a,c1.6 (1.1)b,c26.4
Systemic0.8 (0.7)a,b1.8 (0.8)a,c2.5 (0.8)b,c62.9
Respiratory0.6 (0.5)a,b1.3 (0.6)a,c1.7 (0.6)b,c47.7
GI0.4 (0.4)a,b0.8 (0.6)a,c1.3 (0.9)b,c32.7
Senses1.2 (1.5)a,b1.9 (1.6)a2.2 (1.6)b5.6
Total (not including senses)0.6 (0.5)a,b1.4 (0.6)a,c1.9 (0.6)b,c74.4
Total0.6 (0.5)a,b1.4 (0.6)a,c1.9 (0.5)b,c64.1

Data are presented as mean (standard deviation) unless otherwise indicated.

Abbreviations: GI, gastrointestinal; ILI, influenza-like illness.

No/mild symptoms compared with moderate symptoms (P<.05).

No/mild symptoms compared with severe symptoms (P<.05).

Moderate symptoms compared with severe symptoms (P<.05).

Table 3.

Test of Known-Groups Validity, as Assessed by FLU-PRO Plus, Comparing FLU-PRO Plus Domain and Total Scores With 3 Categories of Severity on the Patient Global Assessment of Influenza-like Illness Scale, Using Analysis of Variance and Pairwise t Tests

Scale Patient Global Assessment of ILI SeverityF Value
No/Mild Moderate Severe/Very Severe
(n=148)(n=63)(n=15)
Nose1.0 (0.8)a,b1.5 (1.0)a1.8 (1.2)b10.5
Throat0.4 (0.7)a,b1.2 (1.0)a1.4 (0.9)b24.7
Eyes0.3 (0.6)a,b0.9 (1.0)a,c1.6 (1.1)b,c26.4
Systemic0.8 (0.7)a,b1.8 (0.8)a,c2.5 (0.8)b,c62.9
Respiratory0.6 (0.5)a,b1.3 (0.6)a,c1.7 (0.6)b,c47.7
GI0.4 (0.4)a,b0.8 (0.6)a,c1.3 (0.9)b,c32.7
Senses1.2 (1.5)a,b1.9 (1.6)a2.2 (1.6)b5.6
Total (not including senses)0.6 (0.5)a,b1.4 (0.6)a,c1.9 (0.6)b,c74.4
Total0.6 (0.5)a,b1.4 (0.6)a,c1.9 (0.5)b,c64.1
Scale Patient Global Assessment of ILI SeverityF Value
No/Mild Moderate Severe/Very Severe
(n=148)(n=63)(n=15)
Nose1.0 (0.8)a,b1.5 (1.0)a1.8 (1.2)b10.5
Throat0.4 (0.7)a,b1.2 (1.0)a1.4 (0.9)b24.7
Eyes0.3 (0.6)a,b0.9 (1.0)a,c1.6 (1.1)b,c26.4
Systemic0.8 (0.7)a,b1.8 (0.8)a,c2.5 (0.8)b,c62.9
Respiratory0.6 (0.5)a,b1.3 (0.6)a,c1.7 (0.6)b,c47.7
GI0.4 (0.4)a,b0.8 (0.6)a,c1.3 (0.9)b,c32.7
Senses1.2 (1.5)a,b1.9 (1.6)a2.2 (1.6)b5.6
Total (not including senses)0.6 (0.5)a,b1.4 (0.6)a,c1.9 (0.6)b,c74.4
Total0.6 (0.5)a,b1.4 (0.6)a,c1.9 (0.5)b,c64.1

Data are presented as mean (standard deviation) unless otherwise indicated.

Abbreviations: GI, gastrointestinal; ILI, influenza-like illness.

No/mild symptoms compared with moderate symptoms (P<.05).

No/mild symptoms compared with severe symptoms (P<.05).

Moderate symptoms compared with severe symptoms (P<.05).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close